| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.13▲ | 3.13▲ | 3.14▲ | 3.22▼ | 3.30▼ |
| MA10 | 3.13▲ | 3.14▲ | 3.18▼ | 3.19▼ | 3.29▼ |
| MA20 | 3.12▲ | 3.18▼ | 3.24▼ | 3.31▼ | 3.31▼ |
| MA50 | 3.13▲ | 3.23▼ | 3.21▼ | 3.34▼ | 3.53▼ |
| MA100 | 3.18▼ | 3.21▼ | 3.24▼ | 3.32▼ | 3.04▲ |
| MA200 | 3.24▼ | 3.26▼ | 3.36▼ | 3.45▼ | 2.93▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.005▲ | -0.001▼ | -0.016▼ | -0.007▼ | -0.004▼ |
| RSI | 66.345▲ | 45.707▼ | 43.122▼ | 43.068▼ | 45.461▼ |
| STOCH | 57.083 | 33.544 | 12.547▼ | 52.616 | 51.971 |
| WILL %R | -17.647▲ | -65.000 | -70.213 | -71.111 | -54.412 |
| CCI | 257.594▲ | 17.710 | -53.733 | -50.322 | -40.410 |
|
Friday, June 27, 2025 10:02 AM
US biotech Arbutus Biopharma (Nasdaq: ABUS) has reacquired the rights to its lead hepatitis B candidate, imdusiran (AB-729), in China, ending a nearly four-year partnership with Qilu .
|
|
Tuesday, June 24, 2025 05:00 PM
The latest price target for Arbutus Biopharma (NASDAQ:ABUS) was reported by Chardan Capital on March 28, 2025. The analyst firm set a price target for $5.00 expecting ABUS to rise to within 12 ...
|
|
Sunday, May 25, 2025 04:30 AM
A shot of a laboratory team in lab coats and safety gloves preparing biopharmaceuticals. Arbutus Biopharma Corporation (NASDAQ:ABUS) is not on our list of 31 Most Popular Stocks Among Hedge Funds ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/07/25 | 3.25 | 3.26 | 3.10 | 3.17 | 1,124,597 |
| 10/07/25 | 3.32 | 3.335 | 3.235 | 3.28 | 859,973 |
| 09/07/25 | 3.23 | 3.36 | 3.205 | 3.34 | 1,167,935 |
| 08/07/25 | 3.15 | 3.225 | 3.12 | 3.18 | 544,025 |
| 07/07/25 | 3.22 | 3.24 | 3.11 | 3.14 | 598,800 |
| 03/07/25 | 3.20 | 3.28 | 3.1884 | 3.24 | 354,262 |
| 02/07/25 | 3.18 | 3.28 | 3.145 | 3.19 | 599,655 |
| 01/07/25 | 3.07 | 3.23 | 3.06 | 3.18 | 892,801 |
| 30/06/25 | 3.12 | 3.12 | 3.04 | 3.09 | 1,126,051 |
| 27/06/25 | 3.19 | 3.22 | 3.12 | 3.13 | 1,839,167 |
|
|
||||
|
|
||||
|
|